Mario Capasso Advances in Neuroblastoma Research Congress 2016

Abstracts this author is presenting:

• Whole exome and deep targeted sequencing of clinically aggressive neuroblastomas reveal recurrent somatic mutations in pathways involved in cancer progression — Parallel 13 - Genome Wide Analysis and Genetic Variation
• A high-throughput drug screening of FDA approved anti-cancer compounds suggests candidate tyrosine kinase inhibitors for repositioning in neuroblastoma therapy — Poster Session 2 with wine & cheese